Copyright
©The Author(s) 2017.
World J Immunol. Jul 27, 2017; 7(2): 11-23
Published online Jul 27, 2017. doi: 10.5411/wji.v7.i2.11
Published online Jul 27, 2017. doi: 10.5411/wji.v7.i2.11
Basic observations | Interpretation |
Chronic inflammation increases cancer risk | Causality is not proven[47] |
Inflammation from psoriasis actually reduces cancer risk | |
AIs decrease cancer | AIs are proven to decrease cancer risk as shown in Coley’s toxin[93] |
AIs may mobilize strong immune responses and create cancer resisting environment[94,95] | |
Metabolic inflammation may be an important risk factor | Causality is quite possible, via IGF, VEGF |
Various type of immune, inflammatory cells are present in cancer loci | They can be innocent bystanders |
Immune cells affect malignant cells through cytokines, chemokines, growth factors, prostaglandins, and reactive oxygen and nitrogen species | This fact proves that there is an interaction between immune cells and cancer cells but causal relationship is yet to be established |
Inflammation is present from tumor initiation to metastasis | It does not mean inflammation causes cancer. Inflammation may be a part of disease processes in cancer |
NF-κB signaling pathway can be two-way street: NF-κB from immune system can suppress cancer progress; also NF-κB from cancer cells to resist immune action | NF-κB is universal biologic transcription factor and difficult to prove its involvement as a causal factor in carcinogenesis |
Certain immune/inflammatory actions are dispensable in some stages and indispensable in others |
- Citation: Janket SJ, Qureshi M, Bascones-Martinez A, González-Febles J, Meurman JH. Holistic paradigm in carcinogenesis: Genetics, epigenetics, immunity, inflammation and oral infections. World J Immunol 2017; 7(2): 11-23
- URL: https://www.wjgnet.com/2219-2824/full/v7/i2/11.htm
- DOI: https://dx.doi.org/10.5411/wji.v7.i2.11